Literature DB >> 14766858

Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02).

Alessandra Amendola1, Licia Bordi, Claudio Angeletti, Enrico Girardi, Giuseppe Ippolito, Maria R Capobianchi.   

Abstract

LCx was compared to other assays in measuring human immunodeficiency virus type 1 (HIV-1) CRF02 viremia. LCx showed significant but low correlation with the other methods. Values of <2.60 log(10) cp/ml were observed in 29.6% of specimens with LCx and in only 14.8% with bDNA and PCR, suggesting suboptimal performance of LCx with CRF02.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14766858      PMCID： PMC344458          DOI： 10.1128/JCM.42.2.811-815.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  27 in total

1.  Impact of HIV type 1 subtype variation on viral RNA quantitation.

Authors:  B Parekh; S Phillips; T C Granade; J Baggs; D J Hu; R Respess
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-20       Impact factor: 2.205

2.  HIV-1 subtypes and plasma RNA quantification.

Authors:  F Damond; C Apetrei; D Descamps; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

3.  Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors.

Authors:  U Dietrich; H Ruppach; S Gehring; H Knechten; M Knickmann; H Jäger; E Wolf; R Husak; C E Orfanos; H D Brede; H Rübsamen-Waigmann; H von Briesen
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

4.  HIV-1 group O virus identified for the first time in the United States.

Authors:  M A Rayfield; P Sullivan; C I Bandea; L Britvan; R A Otten; C P Pau; D Pieniazek; S Subbarao; P Simon; C A Schable; A C Wright; J Ward; G Schochetman
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

5.  Subtype-specific problems with quantification of plasma HIV-1 RNA.

Authors:  A Alaeus; K Lidman; A Sönnerborg; J Albert
Journal:  AIDS       Date:  1997-06       Impact factor: 4.177

6.  Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma.

Authors:  A L Dunne; S M Crowe
Journal:  AIDS       Date:  1997-01       Impact factor: 4.177

7.  Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain.

Authors:  Z Debyser; E Van Wijngaerden; K Van Laethem; K Beuselinck; M Reynders; E De Clercq; J Desmyter; A M Vandamme
Journal:  AIDS Res Hum Retroviruses       Date:  1998-03-20       Impact factor: 2.205

8.  An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  D Kern; M Collins; T Fultz; J Detmer; S Hamren; J J Peterkin; P Sheridan; M Urdea; R White; T Yeghiazarian; J Todd
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

9.  Comparison of NucliSens and Amplicor monitor assays for quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Côte d'Ivoire.

Authors:  J N Nkengasong; M Kalou; C Maurice; C Bile; M Y Borget; S Koblavi; E Boateng; M Sassan-Morokro; E Anatole-Ehounou; P Ghys; A E Greenberg; S Z Wiktor
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948
View more
  4 in total

1.  Evaluation of the Abbott investigational use only realtime HIV-1 assay and comparison to the Roche Amplicor HIV-1 monitor test, version 1.5.

Authors:  Michael T Pyne; Eric Q Konnick; Amit Phansalkar; David R Hillyard
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

2.  Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma.

Authors:  Vincent Foulongne; Brigitte Montes; Marie-Noelle Didelot-Rousseau; Michel Segondy
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.

Authors:  Priscilla Swanson; Carmen de Mendoza; Yagnya Joshi; Alan Golden; Richard L Hodinka; Vincent Soriano; Sushil G Devare; John Hackett
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation.

Authors:  A Garcia-Diaz; G S Clewley; C L Booth; W Labett; N McAllister; A M Geretti
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.